I agree CUX is a spec stock, but is becomming less so as the management is as they put it enhancing, expanding and de-risking the resource. A lot can happen between now and actually producing. I should note in my experience the management has never been prone to exaggeration, which is comforting when investing in a spec. So I hope I'm right also, but so far I'm not disappointed from what I have heard from and about CUX. I think the further information due by the end of the year will strengthen the story, but that as you are insinuating, the whole story is yet to be seen.
I think to balance the risk of being a spec stock is the market cap of CUX. LYN has a market cap of 1.5billion while CUX has a market cap 9 million. LYN is 166 times larger than CUX on the basis of market cap. The question is not whether LYN is fairly priced, which I think could be argued it isn't because of the Malaysian experience, but whether CUX is fairly priced in comparision? That is a question to be answered by each individual investor.
The Thorium issue IMO raises interesting questions about the element. Have you looked at the potential use of Thorium as an energy resource? If you are interested have a look at: http://energyfromthorium.com/
It is interesting to reflect that unless you have more than 166 times more invested in LYN over CUX in dollar terms, as a percentage of the companies Market Caps you are more heavily invested CUX than LYN.
Cheers
CUX Price at posting:
6.5¢ Sentiment: Buy Disclosure: Held